Searched for
AKSHIKAR
Maharashtra targets Rs 30 lakh crore inflows to become a global investment hubMaharashtra targets ₹30 lakh crore in investments to become a global hub. The state is focusing on infrastructure, logistics, and clean ene...- GSK India plans big 'reinvention', MD Bhushan Akshikar revealsGlaxoSmithKline Pharmaceuticals is planning a major comeback in India. The company aims to double its revenue to ₹8,000 crore within the ne...
- GSK re-enters India’s cancer drug marketGlaxoSmithKline Pharmaceuticals is re-entering India's oncology market with the launch of Jemperli and Zejula, precision therapies for gyna...
- GSK enters into oncology segment; launches therapies for gynaecological cancersGlaxoSmithKline Pharmaceuticals has entered the oncology segment in India, introducing Jemperli and Zejula for gynaecological cancers. Thes...
- I-Sec upgrades GlaxoSmithKline Pharma to Add, lowers target price to Rs 2,250ICICI Securities has raised its rating on GlaxoSmithKline Pharmaceuticals to Add from Hold with a new target price of Rs 2250. GSK Pharma's...
- GSK Pharma to expand into oncology, focus on adult vaccines in IndiaGlaxoSmithKline Pharma is shifting focus to specialty treatments and preventive healthcare, emphasizing adult vaccines and oncology in Indi...
- GSK's Augmentin is India's no.1 drug brandResearch firm PharmaTrac data shows Augmentin sales at Rs 801 crore from November 2022-23. For the month of November, Augmentin sales stood...
- GSK India Q2 Results: Net profit grows 11% YoY to Rs 216 croreOur Q2 performance reflects an overall recovery with market share gains in several key promoted brands across all business units. We held l...
- GlaxoSmithKline Pharma Q1 Results: Net profit rises 11% to Rs 132 crDespite the strong external headwinds, GSK remains focused on delivering best-in-class competitive performance and driving operational effi...
- GSK India net profit grows 13% to Rs 131 crore in Q1FY24GlaxoSmithKline Pharmaceuticals (GSK India) on Wednesday reported 13% year-on-year (YoY) jump of net profit to Rs 131 crore for the quarter...
- GSK India reports Rs 133 crore net profit in quarter four of FY23GSK India reported a net profit of Rs 133 crore for the quarter ended March 31, 2023, with continued momentum across general medicines and ...
- GSK rolls out its Shingles vaccine in IndiaThe adult vaccine recommended for people aged 50 years and above, provides protection against shingles - a disease associated with debilita...
- GlaxoSmithKline Pharma names Bhushan Akshikar as new Managing DirectorBefore joining GSK, Akshikar spent 15 years with Janssen, Johnson & Johnson in various roles leading both specialty and primary care busine...
- GSK India appoints Bhushan Akshikar as managing directorAkshikar with over 26 years experience within the pharmaceutical industry, joined GSK India in September 2011 to lead the specialty and com...
- Airfares to go up as holiday season approachesTravel trade professionals say air tickets to some destinations are already up by 10-15 % from last month and will climb further as the hol...
- Indian tourists take an offbeat summer breakUsual suspect Western Europe is under a giant cloud of ash and Thailand, which tops every list of inexpensive overseas holiday spots, is be...
- Mercury Travels to undertake expansionFormer Thomas Cook CEO Ashwini Kakkar, who is now heading Mercury Travels, a JV between EIH (Oberoi Hotels), has an-nounced plans to expand...
Load More
